71
Views
1
CrossRef citations to date
0
Altmetric
Review

Recent approaches to periodontal therapy

&
Pages 1219-1226 | Published online: 24 Feb 2005

Bibliography

  • RAMFJORD SP, KNOWLES JW, NISSLE RR et al: longitu- dinal study of periodontal therapy. J. Periodontol. (1973) 44:66-77. Exp. Opin. Pharmacother. (2000) 1(6)
  • LINDHE J, WESTFELT E, NYMAN S et al.: Healing following surgical/non-surgical treatment of periodontal disease. A Clinical study. J. Clin. Periodontol. (1982) 9:115–128.
  • LOESCHE WJ: Clinical and microbiological aspects of chemotherapeutic agents used according to the specific plaque hypothesis. J. Dent. Res. (1979) 58:2404–2412.
  • MOORE WEC, MOORE LVH: The bacteria of periodontal diseases. Periodontology 2000 (1994) 5:66.
  • SLOTS J: Systemic antibiotics in periodontics. J. Periodontol. (1996) 67:831.
  • ZAMBON JJ: Actinobacillus actinomycetemocomitans in human periodontal disease. J. Clin. Periodontol. (1985) 12:1–20.
  • DE GRAAFF J, VAN WINKLEHOFF AJ, GOENE RJ: The role of Actinobacillus actinomycetemocomitans in periodontal disease. Infection (1989) 17:269–271.
  • SANDROS J, PAPAPANOU PN, NANMARK U et al.: Porphy-romonasgingivalisinvades human pocket epithelium in vitro. J. Periodont. Res. (1994) 29:62–69.
  • DAHLEN G, MANJI F, BAELUM V et al.: Putative periodon-top athogens in 'diseased' and 'non-diseased' persons exhibiting poor oral hygiene. J Clin. Periodontol (1992) 19:35–42.
  • PALLASCH TJ: Pharmacokinetic principles of antimi-crobial therapy. Periodontology 2000 (1996) 10:5.
  • MARIOTTI A, MONROE PJ: Pharmacologic management of periodontal diseases using systemically adminis-tered agents. Dent. Clin. North Am. (1998) 42:245.
  • BADERSTEN A, NILVEUS R, EGELBERG J: Four year observations of periodontal therapy. J. Clin. Periodontol. (1987) 14:438–444.
  • LINDHE J, WESTFELT E, NYMAN S et al.: Long-term effect of surgical/non-surgical treatment of periodontal disease. J. Gun. Periodontol. (1984) 11:448–458.
  • VAN WINKELHOFF AJ, RAMS TE, SLOTS J: Systemic antibiotic therapy in periodontics. Periodontology 2000 (1996) 10:45–78.
  • WALKER C: Acquisition of antibiotic resistance in the periodontal microflora. Periodontology 2000 (1996) 10 :79–88.
  • MAGNUSSON I: Local delivery of antimicrobial agentsfor the treatment of periodontitis. Compendium (1998) 1 9:953–964.
  • SOUTHARD GL, DUNN RL, GARRETT S: The drug delivery and biomaterial attributes of the Atrigel technology in the treatment of periodontal diseases. Exp. Opin. Invest. Drugs (1998) 7:1483–1491.
  • GARRETT S, JOHNSON L, DRISKO C et al: Two multi-center studies evaluating locally delivered doxycy-cline hyclate, placebo control, oral hygiene and scaling and root planing in the treatment of periodon-titis. j Periodontol. (1999) 70:490–503.
  • STOLZE K: Concentration of metronidazole inperiodontal pockets after application of metronida-zole 25% dental gel. J. Clin. Periodontol. (1992) 1 9 :698–701.
  • STOLZE K, STELLFELD M: Systemic absorption of metronidazole after application of metronidazole 25% dental gel. J Gun. Periodontol. (1992) 19:693–697.
  • KNOLL-KOHLER E: Metroidazole dental gel as an alternative to scaling and root planing in the treatment of localized adult periodontitis. Is its efficacy proved? Eur. J. Oral Sci. (1999) 107:415–421.
  • AINAMO J, LIE T, ELLINGSTEN BH et al.: Clinicalresponses to subgingival application of a metronida-zole 25% gel compared to the effect of subgingival scaling in adult p erio don titis. j Gun. Periodontol. (1992) 19:723–729.
  • STELZEL M, FLORES-DE-JOCOBY L: Topical metronida-zole application compared with subgingival scaling. J Periodontol (1996) 23:24–29.
  • SOSKOLNE WA, HEASMAN PA, STABHOLZ A et al: Sustained local delivery of chlorhexidine in the treatment of periodontitis: a multicenter study. J Periodontol (1997) 68:119–126.
  • JEFFCOAT MK, BRAY KS, CIANCIO S et al.: Adjunctive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone. J Periodontol (1998) 69:989–997.
  • LANG N: Bleeding on probing. A predictor for the progression of periodontal disease? J Clin. Periodontol (1986) 13:590–596.
  • BADERSTEN A, NILVEUS R, EGELBERG J: Effect of non-surgical periodontal therapy (VIII). Probing attachment related to clinical characteristics. J Clin. Periodontol (1987) 14:425–432.
  • CATON JG, CIANCIO SG, BLIEDEN TM et al: Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. j Periodontol (2000) 71:521–532.
  • CROUT RJ, LEE HM, SCHROEDER K et al.: The 'cyclic' regimen of low-dose doxycycline for adult periodon-titis: A preliminary study. J. Periodontol. (1996) 67:506–514.
  • CATON J, CIANCIO S, CROUT R et al.: Adjunctive use ofsubantimicrobial doxycycline therapy for periodon-titis. J. Dent. Res. (1998) 7 (SI):1001. Abstract 2957.
  • CATON J, BLIEDEN T, ADAMS D et al.: Subantimicrobial doxycycline therapy for periodontitis. J Dent. Res. (1997) 76 (SD:177. Abstract 1307.
  • WALKER C: The acquisition of antibiotic resistance in the periodontal microflora. Periodontology 2000 (1996) 10:79–88.
  • WALKER C, GODOWSKI K, BORDEN L et al.: The effects of sustained release doxycycline on the anaerobic flora and antibiotic-resistant patterns in subgingival plaque and saliva. J. Periodontol (2000) 71:768–774.
  • TERRANOVA V, WIKESJO UME: Extracellular matrices and polypeptide growth factors as mediators of functions of cells of the periodontium. j Periodontol. (1987) 58:371–380.
  • AMERICAN ACADEMY OF PERIODONTOLOGY POSITIONPAPER: The potential role of growth and differentia-tion factors in periodontal regeneration. J Periodontol. (1996) 67:545–553.
  • GREENHALGH DG, SPRUGEL KH, MURRAY MJ et al: PDGF and FGF stimulate wound healing in the geneti-cally diabetic mouse. Alai. Pathol. (1990) 136:1235–1246.
  • PIERCE GF, VANDE BERG J, RUDOLPH R et al: Platelet-derived growth factor-BB and transforming growth factor beta selectively modulate glycosaminoglycans, collagen and myofibroblasts in excisional wounds. Am. J. Pathol. (1991) 139:629–646.
  • SCHULTZ GS, WHITE M, MITCHELL R et al: Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science (1987) 235:350–352.
  • LIU F, VENTURA F, DOODY J: Human Type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor mode to the BMPs. Mol. Cell Biol. (1995) 15:3479–3486.
  • SAKAUE M, KITAZAWA S, NISHIDA K: Molecular cloning and characterization of human bone morphogenic protein (BMP)-5 gene promoter. Biochem. Biophys. Res. Commun. (1996) 221:768–772.
  • FERGUSON CM, MICLAU T, HU D: The common molecular pathways in skeletal morphogenesis and repair. Ann. NY Acad. ScL (1998) 857:33–42.
  • BOWERS G, FELTON F, MIDDLETON C et al: Histologic comparison of regeneration in human intrabony defects when osteogenin is combined with demineralized freeze-dried bone allograft and with purified bovine collagen. J. Periodontol. (1991) 62:690–702.
  • MASON JM, GRANDE DA, BARCIA M: Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair. Gene Ther. (1998) 5:1098–2104.
  • RAJSHANKAR D, MCCULLOCH CA, TENENBAUM HC: Osteogenic inhibition by rat periodontal ligament cells: modulation of bone morphogenic protein-7 activity in vivo. Cell Tissue Res. (1998) 294:475–483.
  • HEIJL L, HEDEN G, SVARDSTROM G et al: Enamel matrixderivative (Emdogain®) in the treatment of intrabony periodontal defects. J. Clin. Periodontol. (1997) 24 :705–714.
  • SCULEAN A, DONOS N, WINDISCH P et al.: Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. Periodont. Res. (1999) 34:310–322.
  • PONTORIERO R, WENNSTROM J, LINDHE J: The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. j Clin. Periodontol (1999) 26:833–840.
  • MELLONIG JT: Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. Int. J. Periodont. Rest. Dent. (1999) 19:9–19.
  • LOESCHE WJ: The antimicrobial treatment of periodontal disease: changing the treatment paradigm. Crit. Rev. Oral Biol. Med. (1999) 10:245–275.
  • MAGNUSSON I, CLARK WB, MCARTHUR WP et al.: Treatment of subjects with refractory periodontal disease. J. Clin. Periodontol (1994) 21:628-637. Katherine Karpiniat & Ingvar Magnusson

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.